Junhetang
Junhetang operates traditional Chinese medicine clinics
About Junhetang
Nanjing Nuoyu Medical Service Co., Ltd., which operates under the brand name Junhetang, was established in 2010. The company is positioned in the Traditional Chinese Medicine (TCM) sector, operating a chain of physical clinics complemented by an online consultation platform. This integrated model provides a comprehensive service that includes pre-consultation, ongoing treatment support, and post-treatment follow-up management.
Headquartered in Nanjing, China, Junhetang focuses on delivering high-quality TCM services by blending traditional medical culture with modern IT services. The core of its business is a 360-degree managed care service model centered around TCM principles. The clinics offer a range of traditional therapies such as herbal medicine, acupuncture, and massage. This hybrid 'online-to-offline' approach allows the company to serve a broad client base seeking authentic TCM treatments.
The company's funding history indicates investor confidence in its business model. Junhetang has successfully raised capital from investors including Highlight Capital, China Healthcare Holding, and Qiming Venture Partners. One notable funding round was a Series C venture capital investment of $15.7 million on February 7, 2018, at which point the company was already generating revenue. In total, the company has raised $23.3 million to support its growth and the expansion of its service offerings.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- China
- Employees
- 6
- Open positions
- None listed
- Dealroom signal
- 20.3/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Dietary Supplements, Biotechnology, Superfood, Hospital, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Feb 2018 | $16M | $64M | Highlight Capital | — |
| SERIES B✓Equity / VC | Jul 2016 | — | — | Qiming Venture Partners | — |
Growth signals
Latest recorded traffic for Junhetang is 0 monthly website visits. Junhetang's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Series B and later1 investor entered at this stage
Highlight Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Junhetang on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Junhetang’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







